Company / Shares Outstanding
Cardiff Oncology, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
66.5M
FY2025
5-year range
36.8M / 66.5M
FY2021-FY2025
Trend
+48.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from 44677000.00 to 66524000.00 over the past 2 years.
Based on SEC 10-K filings.
66524000.00 in FY2025 with a 5-year CAGR of +50.6%.
Increased from 44677000.00 to 66524000.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +16.6%
- 5-Year CAGR
- +50.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding increased 48.9% year-over-year.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 66.5M | +48.9% |
| FY2024 | 44.7M | +0.0% |
| FY2023 | 44.7M | +6.5% |
| FY2022 | 42.0M | +14.1% |
| FY2021 | 36.8M | +328.0% |
| FY2020 | 8.6M | +124.3% |
| FY2019 | 3.8M | +422.6% |
| FY2018 | 733.2K | -97.6% |
| FY2017 | 30.7M | +3.2% |
| FY2016 | 29.7M | +57.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026